Egbert F Smit

发表

Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer

Michael J Seckl, Julian Downward, E. Smit, 2016, Cell Discovery.

Monitoring Response to Antiangiogenic Therapy in Non–Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI

Pieter Leffers, Mark Lubberink, Otto S Hoekstra, 2011, The Journal of Nuclear Medicine.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Peter Balter, Joe Y. Chang, Joachim Widder, 2015, The Lancet. Oncology.

Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.

Nick Thatcher, Shengyan Hong, Jacek Jassem, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reproducibility of Tumor Perfusion Measurements Using 15O-Labeled Water and PET

Mark Lubberink, Ronald Boellaard, Otto S Hoekstra, 2008, Journal of Nuclear Medicine.

Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non–Small Cell Lung Cancer Patients

Ronald Boellaard, Otto S Hoekstra, Virginie Frings, 2016, The Journal of Nuclear Medicine.

Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3.

Andreas Schlicker, Anirudh Prahallad, Andrea Bertotti, 2014, Cell reports.

Parametric Methods for Quantification of 18F-FAZA Kinetics in Non–Small Cell Lung Cancer Patients

Ronald Boellaard, Otto S Hoekstra, Maqsood Yaqub, 2014, The Journal of Nuclear Medicine.

An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer

Marcin Skrzypski, Witold Rzyman, Thomas Muley, 2009, Clinical Cancer Research.

Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutations.

William Pao, Gregory J Riely, D Ross Camidge, 2014, Cancer discovery.

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

Johan Nuyts, Otto S Hoekstra, Adriaan A Lammertsma, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Repeatability of Metabolically Active Volume Measurements with 18F-FDG and 18F-FLT PET in Non–Small Cell Lung Cancer

Ronald Boellaard, Otto S Hoekstra, Virginie Frings, 2010, The Journal of Nuclear Medicine.

Time and dose-related changes in radiological lung density after concurrent chemoradiotherapy for lung cancer.

Suresh Senan, David A Palma, E. Smit, 2011, Lung cancer.

Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress

Emanuela Felley-Bosco, E. Smit, R. Stahel, 2014, Molecular oncology.

Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.

Otto S Hoekstra, Adriaan A Lammertsma, Johan Vansteenkiste, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effects of erlotinib therapy on [11C]erlotinib uptake in EGFR mutated, advanced NSCLC

Maqsood Yaqub, Adriaan A Lammertsma, Robert C Schuit, 2016, EJNMMI Research.

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.

Tae Min Kim, Bruce E Johnson, Harry J M Groen, 2016, The Lancet. Oncology.

Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer.

José Miguel Reyes, Jean-Yves Douillard, Michael Lahn, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

Bastien Cabarrou, Thomas Filleron, Juergen Wolf, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.

Suresh Senan, Ben J Slotman, Frank J Lagerwaard, 2012, International journal of radiation oncology, biology, physics.

EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study.

Bauke Ylstra, Daoud Sie, Erik Thunnissen, 2013, Lung cancer.